{"product_id":"medigrowth-haiiku-cali-orange-thc-cbd-flower-balanced-10g","title":"Medigrowth - Haiiku Cali-Orange - THC\/CBD Flower (Balanced) - 10g","description":"\u003cp\u003eHaiiku Cali-Orange is a GMP, pharmaceutical-grade, balanced hybrid flower. It’s hang-dried and hand-trimmed for a quality presentation. The buds feature prominent orange pistils winding throughout, with a sweet citrus aroma reminiscent of orange zest.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePatient access\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHaiiku Cali-Orange can be prescribed via the TGA SAS or Authorised Prescriber (AP) Standard Pathway when standard therapy has failed, caused side effects, or is contraindicated.\u003c\/p\u003e\n\u003cp\u003eCategory 3 THC dried flower like Haiiku Cali-Orange may be considered in the management of anxiety, chronic non-cancer and cancer pain, depression, sleep disorders, and PTSD—particularly for acute or episodic symptoms that require quick relief (ACRE 2021; Bell et al. 2024; TGA 2023, 2024a).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eClinical research\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHaiiku Cali-Orange has been approved for inclusion in the Medigrowth longitudinal observational study (166_2022). Researchers from the Cognitive Neuroscience Unit at Deakin University, in collaboration with Medigrowth Australia, aim to understand how Medigrowth products may support outcomes for patients with chronic pain, CINV, insomnia, epilepsy, cancer pain, and movement disorders.\u003c\/p\u003e","brand":"Medigrowth Australia","offers":[{"title":"Default Title","offer_id":45947529232549,"sku":"MED-178","price":159.0,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0673\/8883\/3957\/files\/Medigrowth-Cali-Orange.png?v=1759455585","url":"https:\/\/herbly.com.au\/products\/medigrowth-haiiku-cali-orange-thc-cbd-flower-balanced-10g","provider":"Herbly","version":"1.0","type":"link"}